Allarity Therapeutics, Inc. Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent
Allarity Therapeutics, Inc. (ALLR) reported Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent of -$121.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-13.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossDerivativeExcludedComponentIncreaseDecreaseAfterAdjustmentsAndTaxParent · last filed 2023-03-13
- Allarity Therapeutics, Inc. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments and tax, parent for the quarter ending 2021-12-31 was $9.66M.
- Allarity Therapeutics, Inc. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments and tax, parent for the quarter ending 2021-09-30 was -$2.29M.
- Allarity Therapeutics, Inc. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments and tax, parent for the quarter ending 2020-12-31 was -$420.00K.
- Allarity Therapeutics, Inc. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments and tax, parent for the quarter ending 2020-09-30 was -$368.00K.
- Allarity Therapeutics, Inc. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments and tax, parent for fiscal 2022 was -$121.00K.
- Allarity Therapeutics, Inc. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments and tax, parent for fiscal 2021 was -$1.97M.
- Allarity Therapeutics, Inc. other comprehensive income (loss), derivative, excluded component, increase (decrease), after adjustments and tax, parent for fiscal 2020 was -$4.16M.
| Period end | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent 3 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent 3 month as first filed | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent 6 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent 9 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent 9 month as first filed | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent 12 month | Other Comprehensive Income (Loss), Derivative, Excluded Component, Increase (Decrease), after Adjustments and Tax, Parent 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2022-12-31 | -$121.00K 10-K · filed 2023-03-13 | ||||||
| 2021-12-31 | $9.66M derived: 10-K 12 month − 10-Q/A 9 month · filed 2023-03-13 | $7.37M derived: sum of 2 quarters · filed 2023-03-13 | -$1.97M 10-K · filed 2023-03-13 | -$28.62M 10-K · filed 2022-05-17 | |||
| 2021-09-30 | -$2.29M 10-Q/A · filed 2022-05-17 | $733.00K 10-Q · filed 2021-11-23 | -$11.63M 10-Q/A · filed 2022-05-17 | -$7.78M 10-Q · filed 2021-11-23 | |||
| 2020-12-31 | -$420.00K derived: 10-K 12 month − 10-Q/A 9 month · filed 2022-05-17 | -$788.00K derived: sum of 2 quarters · filed 2022-05-17 | -$4.16M 10-K · filed 2022-05-17 | ||||
| 2020-09-30 | -$368.00K 10-Q/A · filed 2022-05-17 | $170.00K 10-Q · filed 2021-11-23 | -$3.74M 10-Q/A · filed 2022-05-17 | -$2.68M 10-Q · filed 2021-11-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Pasithea Therapeutics Corp. (KTTA) | United States | $0.017B | -0.81 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Korsana Biosciences, Inc. (CYCN) | United States | $0.016B | |
| Citius Pharmaceuticals, Inc. (CTXR) | United States | $0.016B | -133.06 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| Lantern Pharma Inc. (LTRN) | United States | $0.015B | -2.87 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Anebulo Pharmaceuticals, Inc. (ANEB) | United States | $0.015B |